ライフサイエンスコーパス: human herpesvirus 6

1 and the thymus, kidneys, and adrenal glands (human herpesvirus 6).

2 sivity factors of herpes simplex virus 1 and human herpesvirus 6.

3 new and conserved features in the genome of human herpesvirus 6.

4 galovirus, EBV, adenovirus, BK virus, and/or human herpesvirus 6.

5 reported types of clinical disease caused by human herpesvirus-6.

6 infection with both human herpesvirus-7 and human herpesvirus-6.

7 d: 11 with infectious causes (2 influenza; 2 human herpesvirus 6; 2 group B Streptococcus; 2 Streptoc

8 virus; cytomegalovirus; Epstein-Barr virus; human herpesviruses 6, 7, and 8; or adeno-associated vir

9 Human herpesvirus 6 activity (HHV-6) was studied in 15 a

10 is associated with Epstein-Barr virus and/or human herpesvirus 6 and an inflammatory TME with neutrop

11 Coreactivation of both human herpesvirus 6 and cytomegalovirus in ICU patients

12 The association of human herpesvirus 6 and cytomegalovirus reactivation wit

13 ilation and ICU type, only coreactivation of human herpesvirus 6 and cytomegalovirus was significantl

14 with the detection of cytomegalovirus (CMV), human herpesvirus 6 and human herpesvirus 7 and BK virus

15 -N also inhibited fusion and/or infection by human herpesvirus 6 and measles virus but not by vaccini

16 Co-infections by Epstein-Barr virus, human herpesvirus 6 and/or enterovirus A71 were also det

17 Human herpesvirus-6 and respiratory syncytial virus are

18 Human herpesviruses 6 and 7 (HHV-6 and HHV-7) are preval

19 s of the epidemiology and natural history of human herpesviruses 6 and 7 in infants, a practical meth

20 ing Epstein-Barr virus, cytomegalovirus, and human herpesviruses 6 and 7.

21 virus, cytomegalovirus, Epstein-Barr virus, human herpesviruses 6 and 8, gonorrhea, or chlamydia.

22 IMPORTANCE Human herpesviruses-6 and -7 infect essentially 100% of

23 infections, such as measles, parvovirus B19, human herpesvirus 6, and enteroviruses in developed coun

24 uding BK virus, cytomegalovirus, adenovirus, human herpesvirus 6, and Epstein-Barr virus.

25 ovirus, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and John Cunningham virus.

26 and 2, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and varicella-zoster virus.

27 hain reaction to detect human herpesvirus-7, human herpesvirus-6, and cytomegalovirus DNA in lesional

28 Human herpesvirus-6 can be a pathogen in transplant reci

29 Human herpesvirus-6 can be an opportunistic pathogen in

30 Murine roseolovirus, a homolog of human herpesvirus 6, can also be reactivated in the lung

31 inherits a chromosomally integrated copy of human herpesvirus 6 (CI-HHV-6), but the consequences of

32 esence of inherited chromosomally integrated human herpesvirus 6 (ciHHV-6) in hematopoietic cell tran

33 inical relevance of chromosomally integrated human herpesvirus-6 (CIHHV-6) after transplantation is n

34 Both CMV disease and detection of human herpesvirus 6 DNA were associated with chronic all

35 positivity for either human herpesvirus-7 or human herpesvirus-6 DNA in skin or serum.

36 lls (83%), and serum (100%) samples, whereas human herpesvirus-6 DNA was detected in lesional skin (8

37 are available on the effective prevention of human herpesvirus 6, Epstein-Barr virus, adenovirus, and

38 Viruses (human herpesvirus 6, Epstein-Barr virus, and cytomegalov

39 Human herpesvirus-6 has two variants, designated variant

40 ding measles virus, Neisseria gonorrhea, and human herpesvirus 6, have been described, the region of

41 Cytomegalovirus (CMV) (18.3%), human herpesvirus 6 (HHV-6) (34.2%), human herpesvirus 7

42 targets detected were enterovirus (n = 38), human herpesvirus 6 (HHV-6) (n = 30), and Streptococcus

43 Human herpesvirus 6 (HHV-6) and cytomegalovirus (CMV) ar

44 A potential association between human herpesvirus 6 (HHV-6) and cytomegalovirus (CMV) fo

45 Human herpesvirus 6 (HHV-6) and HHV-7 are closely relate

46 ral reports have suggested an association of human herpesvirus 6 (HHV-6) and multiple sclerosis (MS)

47 Human herpesvirus 6 (HHV-6) and oncogenic Marek's diseas

48 test was developed and used with an existing human herpesvirus 6 (HHV-6) antibody avidity test to det

49 Six immunocompetent patients with human herpesvirus 6 (HHV-6) chromosomal integration had

50 The majority of human herpesvirus 6 (HHV-6) congenital infections (86%)

51 The prevalence and concentration of human herpesvirus 6 (HHV-6) DNA in the cerebrospinal flu

52 Human herpesvirus 6 (HHV-6) DNA levels in peripheral blo

53 The frequency of human herpesvirus 6 (HHV-6) DNA was assessed in autopsy

54 examined the correlation between persistent human herpesvirus 6 (HHV-6) DNAemia (p-HHV-6) and absolu

55 Human herpesvirus 6 (HHV-6) employs the complement regul

56 This review evaluates publications on human herpesvirus 6 (HHV-6) encephalitis recognizing fir

57 Following primary infection, human herpesvirus 6 (HHV-6) establishes a persistent inf

58 esignated DR7, within the SalI-L fragment of human herpesvirus 6 (HHV-6) exhibited transactivation of

59 Human herpesvirus 6 (HHV-6) has been implicated as a cof

60 Several gene fragments of human herpesvirus 6 (HHV-6) have been shown to activate

61 mory subsets of CD4(+) and CD8(+) T cells to human herpesvirus 6 (HHV-6) have not been previously inv

62 The role of human herpesvirus 6 (HHV-6) in disease beyond primary in

63 te concerning the role of herpesviruses, and human herpesvirus 6 (HHV-6) in particular, in AD.

64 HHV-7 is related to human herpesvirus 6 (HHV-6) in terms of both biological

65 Higher incidence of human herpesvirus 6 (HHV-6) infection has been documente

66 Human herpesvirus 6 (HHV-6) infection is common after tr

67 Congenital human herpesvirus 6 (HHV-6) infection results from germl

68 bella, 309 cases of dengue, and 260 cases of human herpesvirus 6 (HHV-6) infection.

69 Serologic studies indicate that human herpesvirus 6 (HHV-6) infects 90 percent of childr

70 Human herpesvirus 6 (HHV-6) is a lymphotropic betaherpes

71 Human herpesvirus 6 (HHV-6) is a lymphotropic herpesviru

72 Human herpesvirus 6 (HHV-6) is a potentially immunosuppr

73 Human herpesvirus 6 (HHV-6) is a ubiquitous T-lymphotrop

74 Human herpesvirus 6 (HHV-6) is an important cause of men

75 Human herpesvirus 6 (HHV-6) is detected in the plasma of

76 ugh first described as a lymphotropic virus, human herpesvirus 6 (HHV-6) is highly neuropathogenic.

77 Human herpesvirus 6 (HHV-6) is susceptible to latency an

78 Human herpesvirus 6 (HHV-6) may be associated with LFUE,

79 Human herpesvirus 6 (HHV-6) species have a unique abilit

80 Human herpesvirus 6 (HHV-6) variant B is frequently iden

81 Human herpesvirus 6 (HHV-6) was detected in specimens fr

82 ts of encephalitis caused by reactivation of human herpesvirus 6 (HHV-6)(1).

83 Human herpesvirus 6 (HHV-6), a common resident virus of

84 Human herpesvirus 6 (HHV-6), a latent lymphotropic and n

85 Recently, human herpesvirus 6 (HHV-6), a newly described beta-herp

86 the presence of herpes simplex virus (HSV), human herpesvirus 6 (HHV-6), Epstein-Barr virus (EBV), c

87 megalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), herpes simplex virus types

88 er herpesviruses, including cytomegalovirus, human herpesvirus 6 (HHV-6), HHV-7, HHV-8, and Epstein-B

89 uses such as Marek's disease virus (MDV) and human herpesvirus 6 (HHV-6), integrate their DNA into ho

90 virus (EBV), herpes simplex virus 1 (HSV-1), human herpesvirus 6 (HHV-6), parvovirus B19 (B19V), BK p

91 ted at the left and right genomic termini of human herpesvirus 6 (HHV-6), respectively.

92 r a candidate multiple sclerosis (MS) virus, human herpesvirus 6 (HHV-6), was sought in biopsy specim

93 ntly reactivated in HIV-infected patients is human herpesvirus 6 (HHV-6), which has been proposed as

94 have performed a screen aimed at identifying human herpesvirus 6 (HHV-6)-encoded proteins that modula

95 , cytomegalovirus (CMV), BK virus (BKV), and human herpesvirus 6 (HHV-6).

96 onent of multiple sclerosis, the neurotropic human herpesvirus 6 (HHV-6).

97 Human CD46 is a cellular receptor for human herpesvirus 6 (HHV-6).

98 required for its function as a receptor for human herpesvirus 6 (HHV-6).

99 Here, we show that human herpesvirus 6 (HHV-6, A or B) RNA was detected in

100 Here, we describe a human herpesvirus 6 (HHV-6A) chemokine, U83A, which bind

101 96-102), a candidate autoantigen for MS, and human herpesvirus-6 (HHV-6 U24, residues 4-10) that is a

102 zoster virus 6% in saliva and 3% in GCF; of human herpesvirus-6 (HHV-6) 6% in saliva and 2% in GCF;

103 Human herpesvirus-6 (HHV-6) A and B are ubiquitous betah

104 Human herpesvirus-6 (HHV-6) and -7 (HHV-7) infections ty

105 In addition, viral copy number of human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV

106 Human Herpesvirus-6 (HHV-6) DNAemia is not rare in inten

107 The clinical impact and relevance of human herpesvirus-6 (HHV-6) infection in liver transplan

108 To investigate whether human herpesvirus-6 (HHV-6) is a causative agent of ence

109 Human herpesvirus-6 (HHV-6) is a neurotropic virus that

110 Human herpesvirus-6 (HHV-6) is a neurotropic virus.

111 Human herpesvirus-6 (HHV-6) is known to reactivate after

112 Previous research has suggested that human herpesvirus-6 (HHV-6) may integrate into host cell

113 A real-time quantitative human herpesvirus-6 (HHV-6) polymerase chain reaction as

114 The new herpesvirus, human herpesvirus-6 (HHV-6), is able to cause clinical i

115 ZV); beta includes cytomegalovirus (CMV) and human herpesvirus-6 (HHV-6); and gamma includes Epstein-

116 Recent studies have linked human herpesviruses 6 (HHV-6) and 7 (HHV-7) with posttra

117 (EBV), BK virus (BKV), adenovirus (ADV), and human herpesvirus 6 (HHV6) were evaluated to determine o

118 cytomegalovirus (CMV), Epstein-Bar virus and human herpesvirus 6 (HHV6), are known to infect neurons.

119 omes of interest were VR of adenovirus, EBV, human herpesvirus 6 (HHV6), cytomegalovirus (CMV), and B

120 , enterovirus, herpes simplex virus 1 and 2, human herpesvirus 6, human parechovirus, varicella-zoste

121 ations of inherited chromosomally integrated human herpesvirus 6 (iciHHV-6) in solid organ transplant

122 wide have inherited chromosomally integrated human herpesvirus 6 (iciHHV-6), yet we know little about

123 Inherited chromosomally integrated human herpesvirus-6 (iciHHV-6) results in the germ-line

124 ers, and one case of viral meningitis due to human herpesvirus 6 in an unvaccinated child in the unex

125 ations in ATRX and CTNNB1 and integration of human herpesvirus-6 in chromosome 11p.

126 enabled detection of human herpesvirus-7 and human herpesvirus-6 in skin and other tissues isolated f

127 positive by qPCR for Epstein-Barr virus and human herpesvirus 6, including the brain cortex (Epstein

128 CMV, herpes simplex virus type 1, and human herpesvirus 6 infection were independently associa

129 and efficacy of prophylactic strategies for human herpesvirus-6 infection in transplant recipients.

130 Prophylaxis of human herpesvirus-6 infection is feasible in transplant

131 miology, clinical features, and treatment of human herpesvirus-6 infection were manually abstracted f

132 Human herpesvirus 6 is associated with a variety of comp

133 expanded panel of HHV-6B antigens.IMPORTANCE Human herpesvirus 6 is highly prevalent and maintains ch

134 Human herpesvirus 6 is the causative agent of roseola in

135 rompt recognition of disease associated with human herpesvirus-6 is important because this virus is s

136 ncluding adenovirus, bocavirus, coronavirus, human herpesvirus-6, lymphocytic choriomeningitis virus,

137 cause it can depress cell-mediated immunity, human herpesvirus-6 may facilitate superinfection by oth

138 ear cells expressing human herpesvirus-7 and human herpesvirus-6 mRNA were identified in perivascular

139 9; p = 0.005) compared to patients with only human herpesvirus 6, only cytomegalovirus, or no viral r

140 n Results: First-onset viral infections with human herpesvirus 6 or Epstein-Barr virus within 100 day

141 30 febrile children positive for adenovirus, human herpesvirus 6, or enterovirus infection or with ac

142 ohistochemical staining for the P41 and P101 human herpesvirus 6 protein antigens showed numerous imm

143 The marrow-suppressive effect of human herpesvirus-6 ranged from transient or self-limite

144 Most patients with human herpesvirus 6 reactivation also reactivated cytome

145 Human herpesvirus 6 reactivation in chimeric antigen rec

146 ical ventilation, burn ICU, major infection, human herpesvirus 6 reactivation, and cytomegalovirus re

147 y and comprehensively assessed the impact of human herpesvirus 6 reactivation, and its interaction wi

148 Human herpesvirus-6 resembles cytomegalovirus in its ant

149 pinal fluid studies revealed the presence of human herpesvirus 6, variant B, DNA in all of 3 patients

150 As do human herpesvirus 6 variants A and B (HHV-6A and -6B), H

151 Human herpesvirus 6 variants A and B (HHV-6A and HHV-6B)

152 Human herpesvirus 6 viremia occurred in 23% of patients

153 ied through a MEDLINE search from 1986 (when human herpesvirus-6 was discovered) to the present, bibl

154 stein-Barr virus (EBV), cytomegalovirus, and human herpesvirus 6 were assessed by semiquantitative po